Clinical Trial Update: Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III [Phase 1]

View source ↗

Summary

Phase 1 trial completed evaluating pharmacokinetic and pharmacodynamic parameters to assess bioequivalence between Julphar Insulin 30/70 and Huminsulin Profil I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Huminsulin Profil III (insulin human)
• Julphar Insulin 30/70 (insulin human 30/70)

Snippet

Sponsor: Julphar Gulf Pharmaceutical Industries | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED